Robin Maximilian Awad

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck et al. · Journal of Nuclear Medicine · 2021 · 41 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development

Yannick De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad et al. · Cancers · 2020 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry

Dora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad et al. · Pharmaceuticals · 2021 · 33 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Targeted α-Therapy Using²²⁵Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens et al. · Journal of Nuclear Medicine · 2023 · 27 citations · Full text

Medicine, Immunology, Oncology +17

Emerging applications of nanobodies in cancer therapy

Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens et al. · International review of cell and molecular biology · 2022 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +12